1Skjaerven R, Vatten LJ, Wilcox AJ, et al. Recurrence of preeclampsia across generations : exploring fetal and maternal genetic components in a population based cohort [J]. BMJ, 2005, 331 (7521) : 877.
2Amgrimsson R, Sigurardttir S, Frigge ML, et al. A genome - wide scan reveals a maternal susceptibility locus for pre - eclampsia on chro- mosome 2p13 [J] . Hum Mol Genet, 1999, 8:1799.
3Jeunemaitre X, Inoue I, Williams C, et al. Haplotypes of angiotensino- gen in essential hypertension (JJ . Am J Hum Genet, 1997, 60 (6) : 1448.
4Ward K, Hata A, Jeunemaitre X, et al. A molecular variant of angio- tensinogen associated with preeclampsia [ J]. Nat Genet, 1993,4:59.
5Zafarmand MH, Franx A, Sabour S, et al, The M235T variant of the anginotensinogen gene is related to development of self - reported hyper- tension during pregnancy: the prospect- EPIC cohort study [J] . Hy- pertens Res, 2008, 31 (7) : 1299.
6Kaur R, Jain V, Khuller M, et al. Association of angiotensin - conver- ting enzyme gene pelymorphism with pregnancy - induced hypertension [J]. Acta Obstet Gynecol Scand, 2005, 84 (10) : 929.
8Kobashi G, Yamada H, Ohta K, et al. Endothelial nitric oxide synthase gene ( NOS3 ) variant and hypertension in pregnancy ( J) . Am J Med Genet, 2001, 103 (3) : 241.
9Renner W, Kotschan S, Hoffmann C, et al. A common 936C/T muta- tion in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels [ J ]. J Vasc Res, 2000, 37 (6) : 443.
10Shim JY, Jun JK, Jung BK, et al. Vascular endothelial growth factor gene + 936C/T polymorphism is associated with pre -eclampsia in Ko- rean women [J]. Am J Obstet Gynecol, 2007, 197 (3) : 271.
2Pollak ES, Lam HS, Russell JE. The G20210A mutation dose not affect the stability of prothrombin mRNA in vivo [ J ]. Blood, 2002, 100( 1 ) :359-362.
3Hillarp A, Zoller B, Svensson PJ, et al. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis [ J]. Thromb Haemost, 1997, 78(3) :990-992.
4Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prethrombin levels and an increase in venous thrombosis [ J ]. Blood, 1996,88 (10) :3698-3703.
5Pederson OD, Gram J, Jespersen J, et al. Plasminogen in patients activator inhibitor type-1 determines plasmin formation with ischaemic heart disease [J]. Thromb Haemost, 1995,73(5) :835-840.
6Marchiori A, Mosena L, Prins MH, et al. The risk of recurrent venous thromboembolism among hetemzygous carriers of factor V leiden or prothrombin G20210A mutation [ J ]. Haematologica, 2007,92 (8) :1107-1114.
7Di Micco P, Di Fiore R, Niglio A, et al. Different outcome of six homozygotes for prothrombin A21210A gene variant [J]. J Transi Med, 2008,15(6) :36.
8乐杰．妇产科学[M]．6版．北京：人民卫生出版社，2003：154—158．
9Darmochwal K D,Rolinski J,Leszczynska G B,et al.The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients[J].American Journal of Reproductive Immunology(AJRI),2002,48:381-386.
10Tomasz B,Yuji H,Naoko S.Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves's ophthalmopathy[J].Human Immunology,2004,65 (6):632-639.
